This is the company's first solution to treat Early Onset Scoliosis patients, specifically those associated with or at risk of Thoracic Insufficiency Syndrome.
Bone Biologics is focusing development of a bone graft substitute for bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more